Skip to content

Isomorphic Labs vs Recursion

A side-by-side comparison of Isomorphic Labs and Recursion, two Science tools, drawn from Ignaite's continuously-verified listings.

Compared from listings verified as of

Isomorphic Labs

Science

AI-first drug design built on AlphaFold for pharma R&D.

View Isomorphic Labs

Recursion

Science

AI-driven drug discovery on the Recursion OS platform.

View Recursion

At a glance

Feature comparison of Isomorphic Labs and Recursion
AttributeIsomorphic LabsRecursion
CategoryScienceScience
PricingPAIDPAID
LicenseProprietaryProprietary
DeploymentCloudCloud
PlatformsWebWeb
Model support (differs)Self-contained (on-device)
Vendor (differs)Isomorphic LabsRecursion Pharmaceuticals

The honest brief

Isomorphic Labs

Direct lineage to Nobel-winning AlphaFold plus Alphabet backing — few AI-drug shops pair that model pedigree with deep-pocket pharma partnerships.

  • AlphaFold-derived design models
  • Alphabet-backed capital
  • Top-pharma partnerships
  • Nobel-laureate leadership
  • Pharma partnerships only
  • No public product or API
  • No approved drug yet
  • Opaque pricing

Recursion

Runs a vast in-house automated wet lab generating millions of cell experiments weekly, feeding a 50+ petabyte dataset few rivals can match.

  • Recursion OS with LOWE language layer
  • Massive proprietary biology dataset
  • Natural-language target and compound queries
  • Public company with pharma partners
  • No self-serve product or API
  • Partner and internal use only
  • Opaque pricing
  • No approved drug yet